Microenvironment and Immunology Galectin-3 Contributes to Melanoma Growth and Metastasis via Regulation of NFAT 1 and Autotaxin

Melanoma is the deadliest form of skin cancer in which patients with metastatic disease have a 5-year survival rate of less than 10%. Recently, the overexpression of a b-galactoside binding protein, galectin-3 (LGALS3), has been correlated with metastatic melanoma in patients. We have previously shown that silencing galectin-3 in metastatic melanoma cells reduces tumor growth and metastasis. Gene expression profiling identified the protumorigenic gene autotaxin (ENPP2) to be downregulated after silencing galectin-3. Here we report that galectin-3 regulates autotaxin expression at the transcriptional level by modulating the expression of the transcription factor NFAT1 (NFATC2). Silencing galectin-3 reduced NFAT1 protein expression, which resulted in decreased autotaxin expression and activity. Reexpression of autotaxin in galectin-3 silenced melanoma cells rescues angiogenesis, tumor growth, andmetastasis in vivo. Silencing NFAT1 expression inmetastatic melanoma cells inhibited tumor growth and metastatic capabilities in vivo. Our data elucidate a previously unidentified mechanism by which galectin-3 regulates autotaxin and assign a novel role for NFAT1 during melanoma progression. Cancer Res; 72(22); 5757–66. 2012 AACR.

[1]  G. Mills,et al.  Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells. , 2012, The American journal of pathology.

[2]  H. Kuwano,et al.  Transient gene silencing of galectin‐3 suppresses pancreatic cancer cell migration and invasion through degradation of β‐catenin , 2011, International journal of cancer.

[3]  H. Nishina,et al.  Autotaxin Regulates Vascular Development via Multiple Lysophosphatidic Acid (LPA) Receptors in Zebrafish* , 2011, The Journal of Biological Chemistry.

[4]  S. Ishii,et al.  Non-Edg family LPA receptors: the cutting edge of LPA research. , 2011, Journal of biochemistry.

[5]  S. Jonjić,et al.  Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity , 2011, Clinical & Experimental Metastasis.

[6]  G. Mills,et al.  Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression , 2011, Oncogene.

[7]  M. Jankowski.  Autotaxin: Its Role in Biology of Melanoma Cells and as a Pharmacological Target , 2011, Enzyme research.

[8]  J. Viola,et al.  NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis , 2011, Cancer Immunology, Immunotherapy.

[9]  V. Hogan,et al.  Cleavage of galectin‐3 by matrix metalloproteases induces angiogenesis in breast cancer , 2010, International journal of cancer.

[10]  M. Bollen,et al.  Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts , 2010, PloS one.

[11]  D. Roberts,et al.  Autotaxin Signaling via Lysophosphatidic Acid Receptors Contributes to Vascular Endothelial Growth Factor–Induced Endothelial Cell Migration , 2010, Molecular Cancer Research.

[12]  R. Kiss,et al.  Galectins and Gliomas , 2009, Brain pathology.

[13]  N. Samadi,et al.  Inhibition of autotaxin production or activity blocks lysophosphatidylcholine‐induced migration of human breast cancer and melanoma cells , 2009, Molecular carcinogenesis.

[14]  D. Herr,et al.  Lysophosphatidic acid in vascular development and disease , 2009, IUBMB life.

[15]  M. Bar‐eli,et al.  Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma* , 2009, The Journal of Biological Chemistry.

[16]  G. Mills,et al.  β-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid–Mediated Migration and Invasion of Human Breast Tumor Cells , 2009, Molecular Cancer Research.

[17]  Yiling Lu,et al.  Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. , 2009, Cancer cell.

[18]  A. Toker,et al.  Akt/Protein Kinase B and Glycogen Synthase Kinase-3β Signaling Pathway Regulates Cell Migration through the NFAT1 Transcription Factor , 2009, Molecular Cancer Research.

[19]  Yutong Zhao,et al.  Role of acylglycerol kinase in LPA-induced IL-8 secretion and transactivation of epidermal growth factor-receptor in human bronchial epithelial cells. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[20]  M. Bar‐eli,et al.  Tumorigenesis and Neoplastic Progression Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals Its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry , 2010 .

[21]  D. Roberts,et al.  Positive Feedback between Vascular Endothelial Growth Factor-A and Autotaxin in Ovarian Cancer Cells , 2008, Molecular Cancer Research.

[22]  J. Chun,et al.  Lysophospholipid activation of G protein-coupled receptors. , 2008, Sub-cellular biochemistry.

[23]  A. Morris,et al.  Measurement of autotaxin/lysophospholipase D activity. , 2007, Methods in enzymology.

[24]  J. Gershenwald,et al.  Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma , 2006, Clinical Cancer Research.

[25]  J. Hodge,et al.  Lysophosphatidic acid stimulates PC‐3 prostate cancer cell matrigel invasion through activation of RhoA and NF‐κB activity , 2006, Molecular carcinogenesis.

[26]  C. Mummery,et al.  Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development , 2006, Molecular and Cellular Biology.

[27]  G. Prestwich,et al.  Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity. , 2006, Organic letters.

[28]  L. Ramdas,et al.  Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes. , 2005, Cancer research.

[29]  H. Kuwano,et al.  Implication of galectin-3 in Wnt signaling. , 2005, Cancer research.

[30]  Min Chen,et al.  Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. , 2005, Oncogene.

[31]  Y. Kloog,et al.  Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity* , 2004, Journal of Biological Chemistry.

[32]  T. Yoshii,et al.  Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs , 2004, Molecular and Cellular Biology.

[33]  B. Giepmans,et al.  Rac Activation by Lysophosphatidic Acid LPA1Receptors through the Guanine Nucleotide Exchange Factor Tiam1* , 2003, The Journal of Biological Chemistry.

[34]  Y. Honjo,et al.  Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. , 2002, Journal of the National Cancer Institute.

[35]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[36]  R. Finley,et al.  Galectin-3 Translocates to the Perinuclear Membranes and Inhibits Cytochrome c Release from the Mitochondria , 2002, The Journal of Biological Chemistry.

[37]  Y. S. Kim,et al.  Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. , 2001, Cancer research.

[38]  O. Kranenburg,et al.  Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists , 2001, Oncogene.

[39]  H. Inohara,et al.  Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  J. Qin,et al.  Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. , 2000, Molecular cell.

[41]  K. Pienta,et al.  Galectin-3 induces endothelial cell morphogenesis and angiogenesis. , 2000, The American journal of pathology.

[42]  Y. Honjo,et al.  The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. , 1999, Cancer research.

[43]  E. Goetzl,et al.  Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. , 1998, Molecular pharmacology.

[44]  L. Liotta,et al.  Stimulation of Tumor Cell Motility Linked to Phosphodiesterase Catalytic Site of Autotaxin* , 1996, The Journal of Biological Chemistry.

[45]  R. Lotan,et al.  Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. , 1995, The American journal of pathology.

[46]  John L. Wang,et al.  Identification of galectin-3 as a factor in pre-mRNA splicing. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Liotta,et al.  Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. , 1994, Biochemistry.

[48]  S. Barondes,et al.  Galectins. Structure and function of a large family of animal lectins. , 1994, The Journal of biological chemistry.

[49]  S. Barondes,et al.  L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. , 1993, The Journal of biological chemistry.

[50]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.